Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure

International Journal of Cardiology

Volumn 57, Issue 1, 1996, Pages 21-29

  Khoury, Antonio M ^a   Davila, Diego F ^a   Bellabarba, Gabriela ^a   Donis, Jose H ^a   Torres, Argenis ^a   Lemorvan, Cecilia ^a   Hernandez, Luis ^a   Bishop, Walter ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Autonomic; Chagas; Converting enzyme inhibitors; Digitalis; Heart failure; Parasympathetic; Sympathetic

Indexed keywords

ALDOSTERONE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METILDIGOXIN; NEUROHORMONE; NORADRENALIN; RENIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CHAGAS CARDIOMYOPATHY; DIGITALIS GLYCOSIDES; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PARASYMPATHETIC NERVOUS SYSTEM; RENIN; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030589154     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02776-3     Document Type: Article

References (49)

1. [1] Bellabarba G, Davila DF, Torres A, Donis JH, Gonzalez JC, Figueroa O, Vasquez CJ, Faddoul M, Khoury A. Plasma renin activity in chagasic patients with and without congestive heart failure. Int J Cardiol 1994; 47: 5-11.
2. [2] Davila DF, Bellabarba G, Hernandez L, Calmon G, Torres A, Donis JH, Barboza JS, Lemorvan C, Gonzalez JG. Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease. Int J Cardiol 1995; 49: 145-151.
3. [3] Carrasco HA, Barboza JS, Inglessis G, Fuenmayor AM, Molina C. Left ventricular cineangiography in Chagas' heart disease: detection of early myocardial damage. Am Heart J 1982; 104: 595-602.
4. [4] Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy. Cardiology 1995; 86: 1-7.
5. [5] Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-254.
6. [6] Packer M. How should physicians view heart failure?. The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1992; 71: 3C-11C.
7. [7] Gheorghiade M, Ferguson DW. Digoxin. A neurohormonal modulator in heart failure?. Circulation 1991; 84: 2181-2166.
8. [8] Ferguson DW. Sympathetic mechanisms in heart failure. Pathophysiological and pharmacological implications. Circulation 1993; 87 (SVII): VII68-VII75.
9. [9] Todd PA, Goa KL. Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure. Drugs 1989; 37: 141-151.
10. [10] Swedberg K, Eneroth P, Kjekshus J, Snapinn S. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure. Am J Cardiol 1990; 66: 40D-45D.
11. [11] Swedberg K, Eneroth P, Kjekshus J, Wilhelsen L. For the Consensus Trial Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-1736.
12. [12] Amorim DS, Manco JC, Gallo Jr L, Marin Neto JA. Chagas' heart disease as an experimental model for studies of cardiac autonomic function in man. Mayo Clin Proc 1982; 57 (Suppl): 46-60.
13. [13] Oliveira ISM, Marin-Neto JA, Editorial Note: Parasympathetic impairment in Chagas' disease. Cause or consequence?. Int J Cardiol 1988; 21: 153-156.
14. [14] Oliveira JSM. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am Heart J 1985; 110: 1092-1098.
15. [15] Oisa D, De Quattro V, De-Ping LEE, Elkayam U, Caeiro T, Palmero H. Pathogenesis of cardiac neuromyopathy in Chagas' disease and the role of the autonomic nervous system. J Autonom Nerv Syst 1990; 30: 583-591.
16. [16] Iosa D, De Quattro V, De-Ping LEE, Elkayam U, Palmero H. Plasma norepinephrine in Chagas' cardioneuropathy: a marker of progressive dysautonomia. Am Heart J 1980; 117: 882-887.
17. [17] Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kerph JS, Kienzle MG. Sympathoinhibitory responses to digitalis in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 1989; 80: 65-77.
18. [18] Thames MD, Waickman LA, Abboud FM. Sensitization of cardiac receptors (vagal afferents) by intracoronary acetylstrophantidine. Am J Physiol 1980; 239: H628-H635.
19. [19] Francis GS, Cohn JN, Johnson G, Rector TS, Golman S, Simon A. For the VHeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II. Circulation 1993; 87 (Suppl VI); VI40-VI48.
20. [20] Batlouni M, Pereira-Barreto AC, Armagailan D, Vichi FL, Spitzer N, Simoes R, Hatab SA, Texeira Nascimento LO. Tratamento da insuficiencia cardiaca leve e moderada com captopril. Estudo multicentrico. Arq Bras Cardiol 1992; 58: 417-421.
21. [21] Szajnbak FEK, Pereira AC, Mady C, Parg JF, Gruppi C, Alfieri RG, Lemos da Luz Pileggi F. Beneficial effects of enalapril on the diastolic ventricular function in Chagas' disease myocardiopathy. Arq Bras Cardiol 1993; 60: 273-276.
22. [22] Dunsel Man PHJM, Kuntze EE, Bruggen AV, Beekhuis H, Piers B, Scat AHJ, Wesselin H, Lie KI. Value of New York Heart Association Classification radionuclide ventriculography and cardiopulmonary exercise test for selection of patients with congestive heart failure studies. Am Heart J 1988; 116: 1475-1482.
23. [23] McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1456.
24. [24] Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in man free of overt cardiovascular disease (The Framingham Heart Study). Am J Cardiol 1992; 70: 1180-1184.
25. [25] Marantz P, Tobin J, Wassertheil-Smoller S, Steingart R, Wexler J, Budner N, Lense L, Wachspress J. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988; 77: 607-612.
26. [26] American Society of Echocardiography. Committee on Standards, Subcommittee on Quantification of two-dimensional Echocardiograms. Recommendations for quantification of left ventricle by two-dimensional echocardiography. J Am Soc Echocard 1989; 2: 358-367.
27. [27] Wong M, Jonhson G, Shabetai R, Hughes V, Bhat G, Lopez B, Cohn JN. For the V-HeFT VA Cooperative Studies Group. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure: veterans affairs cooperative studies V-HeFT I and II. Circulation 1993; 87: VI-65-VI-70.
28. [28] Maekelt JA. Die Komplementbindungs Reaktion der Chagas Krankheit Z. TropenMed Parasitol 1960; 2: 152-157.
29. [29] Ehepestrom F, Johansson P. A method for very rapid determination of catechols using ion-pairing reverse phase high pressure liquid chromatography with electrochemical detection. Life Sci 1985; 36: 867-871.
30. [30] Anton AH, Syre DF. A study of factors affecting the aluminum-oxide trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962; 138: 360-375.
31. [31] Smith T. Drug therapy: digitalis glycosides. N Engl J Med 1973; 288: 719-726.
32. [32] Gomez JH, Cirillo JV, Irvin JD. Enalapril: a review of human pharmacology. Drugs 1985; (Suppl 1): 13-24.
33. [33] Davila DF, Donis JH, Navas M, Fuenmayor AJ, Torres A, Gottberg CF. Heart rate response to atropine and left ventricular function in Chagas' heart disease. Int J Cardiol 1988; 21: 143-152.
34. [34] Fuenmayor AJ, Rodriguez, Torres A, Donis JH, Navas N, Fuenmayor AM, Davila DF. Valsalva Maneuver: a test of the functional status of cardiac innervation in chagasic myocarditis. Int J Cardiol 1988; 18: 351-356.
35. [35] Guerrero L, Carrasco H, Parada H, Molina C, Chuecos R. Left ventricular mechanics in Chagas' heart disease and dilated cardiomyopathy: an echocardiographic study. Arq Bras Cardiol 1989; 53: 23-27.
36. [36] Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57: 17-22.
37. [37] Packer M, Gheorghiade M, Young JB. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7.
38. [38] Gheorghiade M, Zarowitz BJ. Review of randomized trials of digoxin therapy in patients with chronic heart failure. Am J Cardiol 1992; 69: 48G-63G.
39. [39] Gillis RA, Quest JA. The role of the nervous system in the cardiovascular effects of digitalis. Pharm Rev 1980; 31: 19-97.
40. [40] Zucker IH, Peterson TV, Gilmore JP. Quabain increases left atrial stretch receptor in the dog. J Pharmacol Exp Ther 1980; 212: 230-234.
41. [41] Zucker JH, Earle AM, Gilmore JP. The mechanisms of adaptations of left atrial receptors in dogs with chronic heart failure. J Clin Invest 1977; 60: 323-331.
42. [42] Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 1984; 69: 451-460.
43. [43] Ferguson DW. Digitalis and neurohormonal abnormalities in heart failure and implications for therapy. Am J Cardiol 1992; 69: 24G-33G.
44. [44] Floras JS. Clinical aspects of sympathetic and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 22 (SA): 72A-84A.
45. [45] Marin-Neto JA, Pintya AO, Gallo L Jr, Maciel BC. Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversed after compensation. Am J Cardiol 1991; 67: 604-610.
46. [46] Manco JC, Gallo L Jr, Godoy RA, Marin-Neto JA, Carneiro JJ, Amorim DS. Acute hemodynamic effects of digitalis on chronic Chagas' heart disease. Arq Bras Cardiol 1974; 27: 25-35.
47. [47] Binkley PF, Haas GJ, Starling RC. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1995; 25: 289-294.
48. [48] Davila DF, Beblabarba G, Donis JH, Torres A, Rossell O, Figueroa O, Amaro M, Vasquez CJ. Cardiac autonomic control mechanisms in Chagas' heart disease. Therapeutic implications. Med Hypothesis 1993; 40: 33-37.
49. [49] Bestetti R, Coutinho-Neto JA, Staibano L, Pinto LZ, Muallo G, Oliveira JSM. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology 1995; 20: 825-828.